1.    He S, Wu L, Li X, Sun H, Xiong T, Liu J, et al. Metal-organic frameworks for advanced drug delivery. Acta Pharm Sin B. 2021;11(8):2362-2395.
2.    Zhao J, Yin F, Ji L, Wang C, Shi C, Liu X, et al. Development of a tau-targeted drug delivery system using a multifunctional nanoscale metal–organic framework for Alzheimer’s disease therapy. ACS Appl Mater Interfaces. 2020;12(40):44447-44458.
3.    Niu H, Bu H, Zhao J, Zhu Y. Metal–organic frameworks‐based nanoplatforms for the theranostic applications of neurological diseases. Small. 2023;19(23):2206575.
4.    Alahri MB, Arshadizadeh R, Raeisi M, Khatami M, Sajadi MS, Abdelbasset WK, et al. Theranostic applications of metal–organic frameworks (MOFs)-based materials in brain disorders: Recent advances and challenges. Inorg Chem Commun. 2021;134:108997.
5.    García-García A, Rojas S, Rodríguez-Diéguez A. Therapy and diagnosis of Alzheimer’s disease: From discrete metal complexes to metal–organic frameworks. J Mater Chem B. 2023;11(30):7024-7040.
6.    Moretti R, Pansiot J, Bettati D, Strazielle N, Ghersi-Egea J-F, Damante G, et al. Blood-brain barrier dysfunction in disorders of the developing brain. Front Neurosci. 2015;9:40.
7.    Indrit S, Şahin A, Tonbul H, Çapan Y. Brain-targeted nanoparticles to overcome the blood-brain barrier. J Pharm Technol. 2020;1(1):25-39.
8.    Kumar S, Jain S, Nehra M, Dilbaghi N, Marrazza G, Kim K-H. Green synthesis of metal–organic frameworks: A state-of-the-art review of potential environmental and medical applications. Coord Chem Rev. 2020;420:213407.
9.    Singh N, Qutub S, Khashab NM. Biocompatibility and biodegradability of metal organic frameworks for biomedical applications. J Mater Chem B. 2021;9(30):5925-5934.
10. Lai X, Jiang H, Wang X. Biodegradable metal organic frameworks for multimodal imaging and targeting theranostics. Biosensors. 2021;11(9):299.